Elzbieta Izbicka

The effects of cytokines and growth factors on osteoblastic cells.

L. Bonewald, N. Ghosh-Choudhury, Di Chen, 1995, Bone.

Preclinical and clinical strategies for development of telomerase and telomere inhibitors.

E. Raymond, D. V. Von Hoff, S. Hilsenbeck, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.

D. V. Von Hoff, M. Moyer, L. Hurley, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay

E. Raymond, G. Mangold, E. Izbicka, 1999, British Journal of Cancer.

Systemic Administration of Acidic Fibroblast Growth Factor (FGF‐1) Prevents Bone Loss and Increases New Bone Formation in Ovariectomized Rats

G. Mundy, B. Boyce, I. Garrett, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients.

E. Raymond, D. V. Von Hoff, G. Clark, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Activity of oxaliplatin against human tumor colony-forming units.

E. Raymond, D. V. Von Hoff, S. Faivre, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony‐forming units, and xenografts

E. Izbicka, S. Weitman, E. V. Van Laar, 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

G-quadruplexes as targets for drug design.

D. V. Von Hoff, O. Fedoroff, R. Wheelhouse, 2000, Pharmacology & therapeutics.